Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NeuroPace (NPCE) Short-term Investments (2020 - 2025)

Historic Short-term Investments for NeuroPace (NPCE) over the last 6 years, with Q3 2025 value amounting to $39.4 million.

  • NeuroPace's Short-term Investments fell 494.06% to $39.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $39.4 million, marking a year-over-year decrease of 494.06%. This contributed to the annual value of $39.3 million for FY2024, which is 1874.33% down from last year.
  • Per NeuroPace's latest filing, its Short-term Investments stood at $39.4 million for Q3 2025, which was down 494.06% from $39.3 million recorded in Q2 2025.
  • Over the past 5 years, NeuroPace's Short-term Investments peaked at $96.7 million during Q3 2021, and registered a low of $16.7 million during Q1 2021.
  • In the last 5 years, NeuroPace's Short-term Investments had a median value of $51.6 million in 2023 and averaged $60.2 million.
  • As far as peak fluctuations go, NeuroPace's Short-term Investments skyrocketed by 72468.13% in 2021, and later crashed by 3635.96% in 2023.
  • Quarter analysis of 5 years shows NeuroPace's Short-term Investments stood at $96.4 million in 2021, then dropped by 26.55% to $70.8 million in 2022, then crashed by 31.65% to $48.4 million in 2023, then fell by 18.74% to $39.3 million in 2024, then increased by 0.1% to $39.4 million in 2025.
  • Its Short-term Investments stands at $39.4 million for Q3 2025, versus $39.3 million for Q2 2025 and $39.2 million for Q1 2025.